Liver transplantation provides a useful and specific therapy for TTR-FAP by allowing for the suppression of the main source of the mutant TTR; it prevents neuropathy progression in approximately 70% of cases with Val30Met mutation on a long-term basis[8,9]. The gene discussed is TTR; the disease is neuropathy.